Qnasl — Class III drug recall D-382-2014
Terminated recall by Teva Pharmaceuticals USA, reported 2014-01-01, distributed nationwide. Defective Delivery System: There is a potential for some units in certain lots of Qnasl Nasal Aerosol 80 mcg m
| Recall number | D-382-2014 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Teva Pharmaceuticals USA, Horsham, PA, United States |
| Recall initiated | 2013-12-04 |
| Classified | 2013-12-20 |
| Reported by FDA | 2014-01-01 |
| Terminated | 2014-08-27 |
| Distributed | Nationwide (US) |
| Quantity | 379,463 inhalers |
| UPC / GTIN / UDI-DI | 00359310210129 |
| NDC | 59310-0210-12 |
| Lot numbers | 01/14, 03/14, 07/14, 08/14, 120004, 120095, 120131, 120271, 120351 |
Product
Qnasl (beclomethasone dipropionate) Nasal Aerosol, 80 mcg per spray, 120 metered sprays, 8.7 g inhaler, Rx only, Manufactured for Teva Respiratory, LLC, Horsham, PA 19044; By: 3M Delivery Systems, Northridge, CA 91324, NDC 59310-210-12, UPC 3 59310 21012 9.
Reason for recall
Defective Delivery System: There is a potential for some units in certain lots of Qnasl Nasal Aerosol 80 mcg metered spray to have clogged stem valves.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-382-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.